What we do
Eliminate hearing loss
as a chronic condition
Rescue Hearing is a life science organization dedicated to developing an array of gene therapies towards eliminating hearing loss symptoms and providing hope for persons experiencing hearing loss and deafness.
PRESS RELEASE
PRESS RELEASE
Myrtelle Licenses Gene Therapy from Rescue Hearing Inc.
Rescue Hearing is thrilled to announce its entry into a Worldwide Exclusive License Agreement with the innovative company Myrtelle, promising to bring cutting-edge solutions to the world of hearing care!
May | 2022
ABOUT US
Rescue Hearing
RHI is a team of internationally recognized physicians, surgeons, scientists, and drug development professionals who share a passion for developing gene therapies for persons with hearing loss.
Dr. Hinrich Staecker
Chief Scientific Officer
Dr. Xue Zhong Liu
Founding Scientific Advisor
Dr. Athanasia Warnecke
Scientific Advisor
Dr. Jeffrey Holt
Scientific Advisor
Our Products
Developing therapeutic solutions for hearing loss
RHI 100
Targets individuals born with progressive hearing loss.
RHI 200
Targets balance disorders. Proof of Concept (POC) studies complete.
RHI 300
Novel vector platform. POC studies underway.
Stay up to date with RHI
for updates and exciting progress
STAY UP TO DATE
Latest Blogs
AWARENESS
TMPRSS3 Mutation | What it is and How it Relates to Genetic Hearing Loss
The transmembrane serine protease 3 (TMPRSS3) gene plays an important role for many of us. It gives important instructions…
AWARDS
Interview With Dr. Staecker: A Closer Look Into His Profession and Major Contributions Within RHI
Dr. Hinrich Staecker is a scientist and trailblazer in the research of life sciences, particularly in the field of hearing loss. His research…
